Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome

World Journal of Gastroenterology - Tập 21 Số 25 - Trang 7860 - 2015
Konstantinos Kargiotis1,2,3,4,5,6,7,8
1Academic Head, Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Campus, University College London Medical School, University College London, Pond Street, NW3 2QG London, United Kingdom.
2Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Campus, University College London Medical School, University College London, NW3 2QG London, United Kingdom
3Department of Endocrinology, Hippocration Hospital, 54124 Thessaloniki, Greece
4Department of Internal Medicine, Medical School, Aristotle University,
5Department of Pathology, Hippocration Hospital, 54124 Thessaloniki, Greece
6Department of Surgery, Royal Free Campus, University College London Medical School, University College London, NW3 2QG London, United Kingdom
7Hippocration Hospital, 54124 Thessaloniki, Greece
8Pleasanton, CA 94588, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3748/wjg.v20.i39.14219

Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014;20:16464-16473.

Fargion S, Porzio M, Fracanzani AL. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol 2014;20:13306-13324.

10.1016/j.jhep.2011.08.016

10.1016/S0140-6736(10)61350-5

10.1016/S0140-6736(10)61272-X

10.5114/aoms.2011.25554

Kargiotis K, Katsiki N, Athyros VG, Giouleme O, Patsiaoura K, Katsiki E, Mikhailidis DP, Karagiannis A. Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report. Curr Vasc Pharmacol 2014;12:505-511.

10.1161/CIRCULATIONAHA.105.169404

10.1161/01.CIR.0000133317.49796.0E

10.1186/1475-2840-9-24

10.1002/hep.20701

10.1056/NEJMoa0907929

10.1016/j.ijcard.2013.06.024

10.1111/j.1872-034X.2012.01034.x

10.1111/j.1872-034X.2011.00849.x

10.1124/jpet.113.211284

10.1016/j.jhep.2014.02.021

10.1097/MCG.0b013e31819c392e

10.1371/journal.pone.0076538

10.1177/1060028013507239

10.1186/1758-5996-5-32

10.3748/wjg.14.2474

10.1016/j.metabol.2008.07.030

10.1016/j.dld.2012.07.009

10.1016/j.bcp.2012.09.011

10.1007/s00535-010-0203-y

10.4239/wjd.v4.i6.365

10.1371/journal.pone.0071817

10.1111/j.1742-1241.2011.02655.x

10.2174/1874192401408010055

10.2337/dc10-0284

10.3748/wjg.v20.i27.9072

10.1152/japplphysiol.00237.2013

10.1016/j.metabol.2006.05.013

10.2174/157016111797484152

Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Milionis HJ, Mikhailidis DP. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004;43:589-599.

10.1093/ndt/gfl538

10.1185/03007995.2011.595782

10.4254/wjh.v6.i11.800

10.1159/000336669

10.1056/NEJMra011775

10.1111/apt.12543

Thông tin
Thông tin xuất bản

World Journal of Gastroenterology

Tập 21 Số 25

7860

Thông tin tác giả